An Interleukin-33-Mast Cell-Interleukin-2 Axis Suppresses Papain-Induced Allergic Inflammation by Promoting Regulatory T Cell Numbers.
about
Roles of IL-33 in Resistance and Tolerance to Systemic Candida albicans InfectionsInterleukin-33 and Mast Cells Bridge Innate and Adaptive Immunity: From the Allergologist's PerspectiveInsights into Group 2 Innate Lymphoid Cells in Human Airway DiseaseAllergen-encoded signals that control allergic responsesThe Skin as a Route of Allergen Exposure: Part I. Immune Components and Mechanisms.Early local immune defences in the respiratory tractControlling the burn and fueling the fire: defining the role for the alarmin interleukin-33 in alloimmunityGenetic variant in IL-33 is associated with idiopathic recurrent miscarriage in Chinese Han population.Tissue Tregs.Oxidized CaMKII promotes asthma through the activation of mast cells.A mast cell-ILC2-Th9 pathway promotes lung inflammation in cystic fibrosis.Role of the IL-33-ST2 axis in sepsis.Innate lymphoid cells: major players in inflammatory diseases.Interleukin 33 is a guardian of barriers and a local alarmin.Regulatory roles of mast cells in immune responses.Roles of basophils and mast cells in cutaneous inflammation.Alarmins and Their Receptors as Modulators and Indicators of Alloimmune Responses.IL-33 Signaling in Lung InjuryInterleukin-33 in health and disease.Type 2 innate lymphoid cell suppression by regulatory T cells attenuates airway hyperreactivity and requires inducible T-cell costimulator-inducible T-cell costimulator ligand interaction.Mechanisms of immune regulation in allergic diseases: the role of regulatory T and B cells.Are ILC2s Jekyll and Hyde in airway inflammation?Innate and adaptive type 2 immunity in lung allergic inflammation.IL-33: biological properties, functions, and roles in airway disease.Innate lymphoid cells at the interface between obesity and asthma.IL-33 contributes to sepsis-induced long-term immunosuppression by expanding the regulatory T cell population.IL-1R1-MyD88 axis elicits papain-induced lung inflammation.Der f 31, a novel allergen from Dermatophagoides farinae, activates epithelial cells and enhances lung-resident group 2 innate lymphoid cells.Regulatory T Cell Numbers in Inflamed Skin Are Controlled by Local Inflammatory Cues That Upregulate CD25 and Facilitate Antigen-Driven Local ProliferationUlinastatin ameliorates tissue damage of severe acute pancreatitis through modulating regulatory T cells.Memory-type ST2+CD4+ T cells participate in the steroid-resistant pathology of eosinophilic pneumoniaIL-10, TGF-β, and glucocorticoid prevent the production of type 2 cytokines in human group 2 innate lymphoid cells.Group 2 Innate Lymphoid Cells Exhibit a Dynamic Phenotype in Allergic Airway Inflammation.Alternative activation generates IL-10 producing type 2 innate lymphoid cells.Interactions between Innate Lymphoid Cells and Cells of the Innate and Adaptive Immune System.Eosinophils: The unsung heroes in cancer?Interleukin-33 (IL-33): A nuclear cytokine from the IL-1 family.Targeting IL-33/ST2 signaling: regulation of immune function and analgesia.Upper Respiratory Symptoms, Gut Health and Mucosal Immunity in Athletes.IL-33 and IgE stimulate mast cell production of IL-2 and regulatory T cell expansion in allergic dermatitis.
P2860
Q26747318-C0C44F63-421C-49FF-8C9C-120D14D0BB1FQ26775911-7FEA1A6E-4294-4E31-A0F8-E7C04B10EA83Q28076134-64703E08-E52D-4406-9499-4CAEB7FCC5DDQ28080818-92A4784D-F10E-4D1F-82BA-BFE37E494230Q30274806-83EEF750-6C2F-4F36-839F-6AA5735407F7Q33824093-206D58A2-6852-4FF7-ABE1-624E93BDF641Q36440299-1B82C9ED-9084-447E-8865-2C9BD0E57420Q36741487-D00F5106-BA65-4DC8-9D9C-0410F5F138E7Q37088061-BC9375A5-4CB0-4F01-A24B-91E76FCA88CDQ37558095-2B7EA22B-212F-4063-BC37-387DF9198B80Q37591319-9EDF279C-2378-485A-A1E3-E222A1A2539DQ37620811-CE1DED5C-F897-4FB6-9B53-0A52C49435AAQ38643190-214AA068-9112-47C3-98E4-4E7B225462E0Q38702558-99BE47E2-1D78-4526-9146-0121133DA5D5Q38827858-1BCB2AEE-0D1F-472B-9DA6-98C44F683BDBQ38832477-8E0DEFDC-E335-407B-AB2C-803BFECA08DFQ38845953-54357706-33A1-432E-8028-14A65347AEE1Q38930643-16507EAA-AF36-4722-9C47-D14D79CB476DQ38957840-F7982E51-20BA-4458-A32B-639CDA01CF2CQ39311005-DA60D4C4-7E67-4555-805C-CDDB6F0FF07FQ39402881-A77016DE-E036-4D77-8207-B844BB90638EQ39402910-841F3FCD-E803-4CDB-8ACB-16AF8142F9CBQ39402938-A3766E55-7377-4A83-A122-FFEF8DEDDC37Q39402943-82D83970-5300-425B-A33B-6A17F3EB25DAQ40062668-A790B39E-56EF-4C4F-8D13-D42E33AE8A8EQ40265668-A9718D68-710C-46DC-8861-8BA207C32011Q40467026-BB467DD9-5231-4CD1-A800-84CC0EC45A92Q41447045-0E5154A9-43B1-4100-88FA-8AE0FC82B141Q41732634-17713732-8501-407B-BEC4-6E299E822266Q41865142-FA99A300-AB72-479F-A54E-E357E795B9A1Q42339208-6FE06750-956E-4768-88BC-383FE8B6391EQ46800389-190613CB-41F6-483D-A739-52176FE4D235Q47095720-A9207522-55E2-4B5C-8895-5475A88C233FQ47132488-6B6D6DEA-D49F-49A4-9461-22BDA5A9B07DQ47186385-0D45E5E3-332C-4F8E-BD95-F68A1FABD7D8Q47225787-7FFEC704-D8D9-4026-9811-AA974E0F932BQ47285890-89D13C29-204C-47D6-B7FE-0639D0427ADBQ47596055-55CFE342-B536-4790-9741-B3F2A4D93C1FQ47649326-9021D9B3-AD2B-49BE-8E7E-48BF5497F93FQ48094416-6D4447EC-7745-4751-9515-32D0714800B6
P2860
An Interleukin-33-Mast Cell-Interleukin-2 Axis Suppresses Papain-Induced Allergic Inflammation by Promoting Regulatory T Cell Numbers.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
An Interleukin-33-Mast Cell-In ...... ing Regulatory T Cell Numbers.
@ast
An Interleukin-33-Mast Cell-In ...... ing Regulatory T Cell Numbers.
@en
type
label
An Interleukin-33-Mast Cell-In ...... ing Regulatory T Cell Numbers.
@ast
An Interleukin-33-Mast Cell-In ...... ing Regulatory T Cell Numbers.
@en
prefLabel
An Interleukin-33-Mast Cell-In ...... ing Regulatory T Cell Numbers.
@ast
An Interleukin-33-Mast Cell-In ...... ing Regulatory T Cell Numbers.
@en
P2093
P2860
P50
P921
P1433
P1476
An Interleukin-33-Mast Cell-In ...... ting Regulatory T Cell Numbers
@en
P2093
Hajime Suto
Hideaki Morita
Hirotoshi Unno
Katsuko Sudo
Keisuke Oboki
Kenichiro Motomura
Kenji Matsumoto
Ko Okumura
Kousuke Miyauchi
P2860
P304
P356
10.1016/J.IMMUNI.2015.06.021
P407
P50
P577
2015-07-01T00:00:00Z